Back to search

Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis

Data up to Jan 2025

Published2009
Citations172
References19

Total Citations Per Year

Abstract

References (19)

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1965 • 1,402 citations

The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment

1999 • 911 citations

Interferons α and β as Immune Regulators—A New Look

2001 • 671 citations

Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

2006 • 578 citations

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β

2004 • 320 citations

Method for Quantification of Brain, Ventricular, and Subarachnoid CSF Volumes from MR Images

1992 • 257 citations

Treatment of multiple sclerosis with an anti–interleukin‐2 receptor monoclonal antibody

2004 • 167 citations

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results

2007 • 163 citations

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

2007 • 139 citations

Clinical scales for multiple sclerosis

1996 • 109 citations

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

2006 • 109 citations

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

2008 • 79 citations

The role of natural killer cells in curbing neuroinflammation

2007 • 47 citations

Human NK Cells Inhibit Cytomegalovirus Replication through a Noncytolytic Mechanism Involving Lymphotoxin-Dependent Induction of IFN-β

2005 • 44 citations

NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis

2008 • 35 citations

Spotlight on anti-CD25: daclizumab in MS.

2008 • 29 citations

STRUCTURE AND CHEMICAL REACTIONS OF THE COBAMIDE COENZYMES

1964 • 29 citations

Correction

2004 • 16 citations

Cited By (0)

No citing papers found in database

Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and… (2009) – Archives of Neurology | Metascience Observatory Explorer